214
Views
9
CrossRef citations to date
0
Altmetric
Original Article

An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis

, , , , , , & show all
Pages 1481-1491 | Accepted 08 May 2007, Published online: 23 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J. N. Plevris & P. C. Hayes. (2007) Treating bleeding oesophageal varices with vasoactive agents:good value for money?. Current Medical Research and Opinion 23:7, pages 1745-1747.
Read now

Articles from other publishers (8)

Rafael Bañares, Agustín Albillos, Mitesh Nakum, Salvador Gea, Angel Varghese & William Green. (2023) An Economic Analysis of Transjugular Intrahepatic Portosystemic Covered Stent Shunt for Variceal Bleeding and Refractory Ascites in a Spanish Setting. Advances in Therapy 40:7, pages 3006-3020.
Crossref
Richard Mattock, Dhiraj Tripathi, Frank O'Neill, Joyce Craig, Jennifer Tanner, David Patch & Guruprasad Aithal. (2021) Economic evaluation of covered stents for transjugular intrahepatic portosystemic stent shunt in patients with variceal bleeding and refractory ascites secondary to cirrhosis. BMJ Open Gastroenterology 8:1, pages e000641.
Crossref
Eman Ibrahim El-Desoki Mahmoud, Doaa H Abdelaziz, Sherief Abd-Elsalam & Noha O. Mansour. (2021) Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial. Frontiers in Pharmacology 12.
Crossref
Ashish Kumar, Sanjeev K. Jha, Vibhu V. Mittal, Praveen Sharma, Barjesh C. Sharma & Shiv K. Sarin. (2015) Addition of Somatostatin After Successful Endoscopic Variceal Ligation Does not Prevent Early Rebleeding in Comparison to Placebo: A Double Blind Randomized Controlled Trial. Journal of Clinical and Experimental Hepatology 5:3, pages 204-212.
Crossref
Jonathan Karnon & Hossein Haji Ali Afzali. (2014) When to Use Discrete Event Simulation (DES) for the Economic Evaluation of Health Technologies? A Review and Critique of the Costs and Benefits of DES. PharmacoEconomics 32:6, pages 547-558.
Crossref
Adam G Testro & Peter W Angus. (2009) Targeting circulatory dysfunction in cirrhosis: Terlipressin and the hepatorenal syndrome. Journal of Gastroenterology and Hepatology 24:11, pages 1707-1709.
Crossref
Aleksander Krag, Tine Borup, Søren Møller & Flemming Bendtsen. (2008) Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome. Advances in Therapy 25:11, pages 1105-1140.
Crossref
Roberto de Franchis & Alessandra DellʼEra. (2008) Novel developments in esophageal vascular disorders. Current Opinion in Gastroenterology 24:4, pages 490-495.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.